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Abstract
Enzymes encoded by the AKR1C1 and AKR1C2 genes are responsible for the metabolism of progesterone and 5a-
dihydrotestosterone (DHT), respectively. The effect of amino acid substitutions, resulting from single nucleotide
polymorphisms (SNPs) in the AKR1C2 gene, on the enzyme kinetics of the AKR1C2 gene product were determined
experimentally by Takashi et al. In this paper, we used homology modeling to predict and analyze the structure of AKR1C1
and AKR1C2 genetic variants. The experimental reduction in enzyme activity in the AKR1C2 variants F46Y and L172Q, as
determined by Takahashi et al., is predicted to be due to increased instability in cofactor binding, caused by disruptions to
the hydrogen bonds between NADP and AKR1C2, resulting from the insertion of polar residues into largely non-polar
environments near the site of cofactor binding. Other AKR1C2 variants were shown to involve either conservative
substitutions or changes taking place on the surface of the molecule and distant from the active site, confirming the
experimental finding of Takahashi et al. that these variants do not result in any statistically significant reduction in enzyme
activity. The AKR1C1 R258C variant is predicted to have no effect on enzyme activity for similar reasons. Thus, we provide
further insight into the molecular mechanism of the enzyme kinetics of these proteins. Our data also highlight previously
reported difficulties with online databases.
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Introduction
The aldo-keto reductase superfamily includes a variety of
oxidoreductases with a common dependence on NADPH for their
enzyme activity[1]. In particular, the AKR1C1 and AKR1C2
genes encode two 3a-hydroxysteroid dehydrogenase isoforms of
the aldo-keto reductase superfamily responsible for the inactiva-
tion and formation of male and female sex hormones[2]. The
enzyme encoded by the AKR1C1 gene catalyzes the transforma-
tion of progesterone into 20a-hydroxyprogesterone and thus plays
a critical role in controlling plasma progesterone levels during
pregnancy[3] (Figure 1). The AKR1C2 gene product stereospe-
cifically metabolizes 5a-dihydrotestosterone (DHT) to 5a-andro-
stane-3a,17b-diol and thus plays a critical role in regulating
androgen receptor signaling in the prostate[4] (Figure 1). DHT is
a key molecule in prostate cancer development and alterations in
the expression of AKR1C2 have been linked to benign prostatic
hyperplasia and prostate cancer[5,6].
Takahashi et al.[4] reported the effect of eleven amino acid
substitutions encoded by the AKR1C2 gene on the activity of the
gene product in vitro. Using the list of non-synonymous single-
nucleotide polymorphisms (SNPs) provided by the AKR website
(www.med.upenn.edu/akr), in turn obtained from the dbSNP
database[7] at the National Center for Biotechnology Information
(NCBI), they created expression constructs for the wild-type
(normal) and eleven variants. Subsequently, they performed a
kinetic analysis to measure both enzyme activity (measured as
Vmax) and substrate binding (measured as Km) in the reduction of
DHT. A significant reduction in enzyme activity was seen in the
F46Y and L172Q variants and a significant increase in substrate
binding was seen in V38A, L172Q, K185E, and R258C[4].
However, not all of the constructs tested correspond to natural
sequence variants (known as single nucleotide polymorphisms or
SNPs). We have previously shown that as many as 8.3% of the
single nucleotide polymorphisms (SNPs) recorded in the dbSNP
are actually single nucleotide differences (SNDs)[8,9]. That is, they
are not SNPs but are artifacts arising from the presence of a
paralogue (i.e., highly similar duplicated) sequence in the genome.
In fact, six variants examined by Takashi et al. [4] appear to be
such artefactual SNDs.
In this paper, we used homology modeling to predict the
structure of the various AKR1C1 and AKR1C2 isoforms derived
from either the actual non-synonymous SNPs in the dbSNP
databases or the AKR1C2 SNDs. By analyzing the local structural
environment around the substituted amino acids, we were able to
develop physiochemical hypotheses as to the effect of the
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substitution on enzyme activity and co-factor binding. Further-
more, we suggest further experiments that could be undertaken to
confirm these findings and thus improve our understanding of the
molecular basis of AKR1C1 and AKR1C2 functionality. Lastly
this paper highlights again the perils associated with some online
databases.
Methods
The list of eleven non-synonymous AKR1C2 SNPs studied by
Takahashi et al.[4] was compared to list provided on the AKR
website (www.med.upenn.edu/akr) as well as the list of AKR1C2
SNPs and the database of SNDs prepared by Musumeci et al.[8].
Finally, all SNPs were reviewed in the current version of the dbSNP
database (October 2010) to check for recent updates. All but one of
the eleven (rs2518043, leading to K185E) were listed on the AKR
website. All eleven were still current compared to the latest version
of dbSNP, although three (rs10618, rs11474, and rs28943580) were
listed as SNPs in both AKR1C2 and AKR1C1. After comparison
with the SND database, only five were confirmed as legitimate SNPs
(rs2854482, rs2854486, rs2518042, rs2518043, and rs28943580)
while another five (rs3207898, rs3207901, rs3207905, rs13933, and
rs10618) were identified as SNDs. rs11474 was not included in the
SNPs tested inMusumeci et al.[8] but was confirmed to be a SND by
using an analogous procedure.
All five SNPs and the six SNDs were subjected to homology
modeling for theoretical comparison with the experimental data.
Table 1 shows the AKR1C2 SNPs and SNDs modeled, the
corresponding amino acid change, and a summary of our findings
along with those of Takahashi et al.
Each variant of the AKR1C2 protein was modeled using
MolIDE[10] and the following procedure. The FASTA format
sequence of AKR1C2 was taken from UniProt[11] (accession
number: P52895) and edited to reflect the amino acid change in
the variant. The edited sequence was compared to the UniRef100
database using PSI-BLAST[12] to construct a sequence profile.
The sequence profile was then used to compare the variant
sequence with the Protein Data Bank (PDB)[13] to identify
proteins of known structure with sequence homology to the
variant. Five crystal structures of human AKR1C2 were identified
with zero E-value and sequence identity of 99%. 1J96[14] was
chosen as a template for homology modeling due to the presence
of the testosterone substrate in the crystal structure; this being the
most similar substrate in any of the potential template structures to
DHT. The homology model was constructed with the position of
the backbone atoms and conserved side-chains assigned according
to the alignment with 1J96. The side chain for the mutated residue
was built using SCWRL4[15].
The list of AKR1C1 SNPs in Musumeci et al.[8] were reviewed
in the current version of the dbSNP database (October 2010) to
check for updates. The three non-synonymous variants were still
current and consistent with the information on the AKR website.
All three were confirmed as SNDs using the SND database[8]. As
noted above, the review of the AKR1C2 SNPs identified three
SNPs also in AKR1C1. Of these, only one was a legitimate SNP:
rs28943580 resulting in a R258C variant. The homology model
for this variant was produced using the same method as described
above. The UniProt sequence for AKR1C1 (accession number:
Q04828) was edited to create the R258C variant. Two
homologous AKR1C1 crystal structures were identified and
1MRQ[3] was chosen as a template due to the presence of the
progesterone substrate in the crystal structure.
Homology models were visualized and molecular graphics
images produced using the UCSF Chimera package from the
Resource for Biocomputing, Visualization, and Informatics at the
University of California, San Francisco (supported by NIH P41
RR-01081)[16].
In order to quantify the structural changes resulting from the
SNPs, the wild type and the SNP variant structures were evaluated
using a range of structure assessment software. The ProSA-
web[17,18] z-score of the variants and the wild types structures
was used to determine any change in the quality of the structure as
a result of the mutation. Verify3D[19,20] was used to check for
improperly built segments. The range of scores over the whole
protein and individual scores for the mutated residues were
compared with the wild type to identify any structural problems
arising from the mutation. MolProbity[21,22] clash scores for both
the whole protein and individual residues were also compared to
identify structural clashes resulting from the mutations. Finally,
naccess (http://www.bioinf.manchester.ac.uk/naccess/naccess.
html), using the method of Lee and Richards[23] was used to
quantify any changes in the absolute accessible surface area of the
side chain as a result of the mutations.
Results
The list of non-synonymous AKR1C2 SNPs, i.e., those resulting
in an amino acid change in the expressed protein, studied by
Takahashi et al.[4] was compared to the database of SNDs
prepared by Musumeci et al.[8] and the legitimate SNPs
(rs2854482, rs2854486, rs2518042, rs2518043, and rs28943580)
were identified. All SNPs and SNDs were subjected to homology
modeling (Table 1). Each variant of the AKR1C2 protein was
modeled using MolIDE[10], as per the procedures detailed under
Materials and Methods, in order to obtain a three-dimensional
structure for each of the variants. Lastly, these homology models
were visualized and molecular graphics images produced using the
UCSF Chimera package from the Resource for Biocomputing,
Visualization, and Informatics at the University of California, San
Francisco (supported by NIH P41 RR-01081)[16]. By visualizing
the position of the substituted amino acid, the other amino acids in
the immediate environment, and the proximity of the substituted
amino acid to the substrate and the cofactor, it is possible to
suggest a physiochemical rationale for the effect, or the lack of any
effect, of the substitution on enzyme kinetics as determined by the
experiments of Takahashi et al.[4]. Figure 2 shows the structure of
AKR1C2, indicating the position of the substrate, cofactor, active
site, and variant residues. The results for each SNP or SND
examined are reported individually in detail below.
Figure 1. Reactions catalyzed by the AKR1C1 and AKR1C2 gene
products. The AKR1C1 gene product catalyzes the transformation of
progesterone into 20a-hydroxyprogesterone (Panel A). The AKR1C2
gene product stereospecifically metabolizes 5a-dihydrotestosterone
(DHT) to 5a-androstane-3a,17b-diol (Panel B).
doi:10.1371/journal.pone.0015604.g001
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Table 1. A list of the non-synonymous AKR1C1 and AKR1C2 SNPs modeled showing the amino acid change and the predicted and
actual effects on enzyme activity, substrate binding, and cofactor binding.
SNP/SND Substitution Effect on enzyme activity (Vmax) Effect on substrate binding (Km)
Effect on cofactor
binding (Km)
SNPs Predicted Actual Predicted Actual Predicted
rs2854482 F46Y Decrease Decrease No change No change* Increase
rs2854486 V111A No change No change* No change No change* No change
rs2518042 K179E No change No change* No change No change* No change
rs2518043 K185E No change No change* No change Decrease No change
rs28943580 R258C (AKR1C2) No change No change* No change Decrease No change
rs28943580 R258C (AKR1C1) No change - No change - No change
SNDs
rs3207898 V38I No change No change* No change No change* No change
rs3207901 V38A No change No change* No change Decrease No change
rs3207905 H47R No change No change* No change No change* No change
rs13933 S87C No change No change* No change No change* No change
rs10618 H170R No change No change* No change No change* No change
rs11474 L172Q Decrease Decrease No change Decrease Increase
The first five SNPs are from AKR1C2 and the last SNP is from AKR1C1. The SNDs are all from AKR1C2. Actual effects on enzyme activity and substrate binding in
AKR1C2 are determined by comparing the experimental values of Vmax and Km for the variant with those of the WT (normal) using data from Table 3 in Takahashi
et al.[4]. An asterisk indicates the difference measured by Takahashi et al. did not reach statistical significance and is thus reported here as ‘‘no change’’. An increase
in Km corresponds to the substrate or cofactor being more weakly bound. No experimental data is provided for AKR1C1 or cofactor binding in AKR1C2 as these were
not studied. The ‘‘predicted’’ data summarizes our findings in this paper. Cells highlighted in bold-italic indicate where the predictions derived from our modeling
agree with the experimental data.
doi:10.1371/journal.pone.0015604.t001
Figure 2. The structure of AKR1C2. The structure shows chain A from the PDB record 1J96. The substrate is shown in pink and the cofactor is
shown in purple. Water molecules are shown in blue. The residues varied as a result of a SNP (F46, V111, K179, K185, and R258) are shown in red and
residues varied as a result of a SND (V38, H47, S87, H170, and L172Q) are shown in cyan. Residues around the active site are shown in light blue.
doi:10.1371/journal.pone.0015604.g002
Functional Analyses of AKR1C1/2 SNPs
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AKR1C2 SNP variants
F46Y variant. The rs2854482 SNP results in the substitution
of tyrosine (single letter amino acid code: Y) for phenylalanine (F)
at position 46 in the protein sequence (in short F46Y). This
exchanges a large hydrophobic residue for a large polar residue.
Figure 3 shows the environment around residue 46 in the
predicted AKR1C2 protein. Both the F and Y residues adopt the
same rotamer. The normal or wild type (WT) F46 (shown in
orange; Figure 3) exists in a generally hydrophobic environment
comprising L19, A269, and V281 (shown in cyan). The exception
is N280 (shown in red), which forms hydrogen bonds with the
adenine ring nitrogen atoms in the NADP cofactor[24] (shown in
purple) and a water molecule (shown in blue).
Substitution of Y for F results in a slight improvement in ProSA-
web z-score, from 211.63 to 211.65, while the Verify3D score is
slightly worse: up to 0.67 from 0.61. The MolProbity clash score
rises from 6.96 to 16.64 and identifies a potential clash between
Y46 and N280 (0.489 A˚): a likely hydrogen bond as noted below.
There is almost no change in the accessible surface area (2.35 to
2.56).
The F46Y substitution (shown in magenta; Figure 3) intro-
duces a polar residue into this largely hydrophobic environment.
The oxygen of Y46 can also form a hydrogen bond with the water
molecule lying between it and N280. This suggests the F46Y
substitution may change the local environment in such a way as to
disrupt the hydrogen bonds of N280 and thus destabilize the
binding of the NADP cofactor.
This finding concurs with, and potentially explains, the previous
experimental findings of Takahashi et al.[4], who showed a
significant reduction in enzyme activity (Vmax) as a result of the
F46Y mutation, as activity would be reduced by poorer cofactor
binding. In addition, they did not find a statistically significant
change in DHT binding. This also concurs with our results as the
F46Y mutation is located at some distance from the testosterone
substrate of the model, suggesting the reduction in enzyme activity
is mediated through the changes to the interaction between the
enzyme and the cofactor rather than the interaction of the former
with the substrate (Table 1).
V111A variant. The V111A variant is a result of the
rs2854486 SNP. It involves the conservative exchange of a small
hydrophobic residue (valine) for a slightly smaller hydrophobic
residue (alanine). Figure S1 shows the environment around residue
111. Residue 111 is located away from the active site of AKR1C2
and on the periphery of the molecule. The environment around
residue 111 is generally hydrophobic, comprising L99, L103,
L106, and A160 (shown in cyan).
The V111A substitution results in a slight worsening in ProSA-
web z-score, from 211.63 to 211.51, while the Verify3D score is
slightly better: down to 0.64 from 0.66. The MolProbity clash
score rises from 6.96 to 16.27 but no new clash arises from the
substitution. There is almost no change in the accessible surface
area (0.00 to 0.37).
The conservative nature of the substitution, its distance from the
active site, and its location on the periphery, suggest V111A would
have no effect on enzyme activity or substrate binding. These data
concur with the findings of Takahashi et al.[4] who showed no
significant difference in either Vmax or Km for the V111A variant
(Table 1).
K179E variant. The K179E variant is a result of the
rs2518042 SNP. It involves the exchange of a large positively
charged residue, lysine (K), for a smaller negatively charged
residue glutamate (E). Figure S2 shows the environment around
residue 179. Both K (shown in orange) and E (shown in magenta)
adopt the same rotamer. The normal (WT) K179 potentially forms
a salt bridge with the neighbouring E149 and E152 (shown in
cyan). In contrast, the K179E variant breaks this salt bridge and,
due to the smaller size of the glutamate residue, draws this
negative charge further into the non-polar core of the protein,
bringing it into proximity with W148, I176, and L182 (shown in
cyan).
Substitution of E for K at position 179 results in a slight
improvement in ProSA-web z-score, from 211.63 to 211.66 and
the Verify3D score: down to 0.28 from 0.37. The MolProbity clash
score rises from 6.96 to 16.08 and identifies a potential clash
between E179 and the P180 backbone (0.464 A˚). There is a slight
increase in the accessible surface area (18.93 to 19.94).
Despite these changes, residue 179 is located in a loop region,
on the surface of the protein, and distant from the active site. As
such, it suggests the change is unlikely to affect either enzyme
activity or substrate binding. This agrees with the findings of
Takahashi et al.[4] who showed no significant difference in either
Vmax or Km for the K179E variant (Table 1).
K185E variant. As for the previous variant, the rs2518043
SNP, results in the exchange of a large positively charged residue,
lysine, for a smaller negatively charged residue, glutamate. Figure
S3 shows the environment around residue 185. Both K and E
adopt the same rotamer. The normal (WT) K185 residue (shown
in orange) exists in a polar environment formed by N11, K209
(shown in cyan), and several water molecules (shown in blue).
Once again, the K185E substitution (shown in magenta) disrupts
these polar interactions and draws the negative charge further into
the non-polar core of the protein, bringing it into proximity with
L177 and L182 (shown in cyan).
The K185E substitution results in no change to the ProSA-web
z-score of 211.63 or the Verify3D score of 0.20. The MolProbity
clash score rises from 6.96 to 16.28 but no new clash arises from
the substitution. The accessible surface area is slightly reduced
(65.99 to 62.70).
Residue 185 is also located in a loop region, on the surface of
the protein, and distant from the active site. As such, it also
Figure 3. The F46Y amino acid substitution in the predicted
AKR1C2 protein disrupts NADP cofactor binding. The environ-
ment of residue 46 shows both the F (orange) and Y (magenta) variants
adopt the same rotamer. The introduction of the polar Y residue into an
otherwise hydrophobic environment is likely to disrupt the hydrogen
bonding (green) between N280 (red) and the NADP molecule (purple)
and nearby water molecule (blue), thereby disrupting NADP binding.
Helix residues 271–278 lie over the top of the area depicted and have
been removed from the image for clarity.
doi:10.1371/journal.pone.0015604.g003
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suggests the change is unlikely to affect either enzyme activity or
substrate binding. This only partially agrees with the findings of
Takahashi et al.[4] who showed no significant difference in Vmax
but did show a reduction in Km for the K189E variant, suggesting
this substitution results in stronger binding of the DHT substrate
(Table 1).
R258C variant. The rs28943580 SNP results in the exchange
of a large positively charged residue, arginine (R), for a smaller
polar residue, cysteine (C) with a thiol group. Figure S4 shows the
environment around residue 258. Both R (shown in orange) and C
(shown in magenta) adopt the same rotamer. The normal (WT)
R258 residue exists in a heterogeneous environment comprising
polar Q262 and Q287 residues and non-polar L261 and F284
residues (shown in cyan). The interaction between the R258 and
the polar residues, along with water molecules (shown in blue)
around the surface of the protein stabilizes this environment.
The R258C substitution (shown in magenta) breaks these
stabilizing interactions and draws the residue deeper into more
hydrophobic core of the protein in proximity to V283, F286, and
L288 (shown in cyan), although presumably the polar Q262
residue, also being present in the local environment, maintains
some stability.
Substitution of C for R results in a slight worsening in ProSA-
web z-score, from 211.63 to 211.56 and also in the Verify3D
score: up to 0.55 from 0.44. The MolProbity clash score rises from
6.96 to 16.29 but no new clash arises due to the substitution. The
accessible surface area drops dramatically from 27.42 to 3.85. This
supports the observation above that the substitution results in the
sidechain being drawn further into the core of the protein.
Once again, this amino acid substitution is located at some
distance from the active site and thus suggests the change is
unlikely to affect either enzyme activity or substrate binding. This
only partially agrees with the findings of Takahashi et al.[4] who
showed no significant difference in Vmax but did show a reduction in
Km for the R258C variant, suggesting this substitution results in
stronger binding of the DHT substrate (Table 1).
AKR1C2 SND variants
The other variants examined by Takahashi et al.[4] were
determined to be SNDs. As such, the protein variants do not occur
naturally. Nonetheless, homology modeling can still be used to
examine the biochemical changes resulting from these engineered
mutations.
V38I variant. The V38I variant corresponds to the rs3207898
SND. It involves the conservative exchange of a small hydrophobic
residue (valine) for a slightly larger hydrophobic residue (isoleucine).
Figure S5 shows the environment around residue 38. Both V
(valine, shown in orange) and I (isoleucine, shown in magenta) adopt
the same rotamer. Residue 38 is located away from the active site of
AKR1C2 in a pre-dominantly hydrophobic environment com-
prising F21, T23, I42, I49, V61, and I65 (shown in cyan). The
conservative nature of the substitution and its distance from the
active site suggest V38I would have no effect on enzyme activity or
substrate binding. These data concur with the findings of Takahashi
et al.[4] who showed no significant difference in either Vmax or Km for
the V38I variant (Table 1).
V38A variant. The SND rs3207901 corresponds to the V38A
variant. Like V38I described above, the variant involves a
conservative exchange of one hydrophobic residue (valine) for
another, slightly smaller, one (alanine). Figure S6 shows again the
environment around residue 38, but with the V (valine, shown in
orange) and A (alanine, shown in magenta) depicted. As noted
above, the environment is pre-dominantly hydrophobic. How-
ever, the mutation to a smaller residue removes the proximal
relationship between residue 38 and the surrounding residues, with
the exception of F21. Nonetheless, the mutation remains distant
from the active site and thus suggests that V38A would also have
no effect on enzyme activity or substrate binding. This only
partially agrees with the findings of Takahashi et al.[4] who showed
no significant difference in Vmax but did show a reduction in Km for
the V38A variant, suggesting this substitution results in stronger
binding of the DHT substrate (Table 1).
H47R variant. The H47R variant corresponds to the
rs3207905 SND. It involves a conservative exchange of one
large, positively charged residue (histidine) for another (arginine).
Figure S7 shows the environment around residue 47. Both H
(histidine, shown in orange) and R (arginine, shown in magenta)
adopt the same rotamer. H47R exists in a hydrophilic
environment comprising D2, Y5, and D78 (shown in cyan),
along with a number of water molecules (shown in blue). H47 is
hydrogen-bonded (shown in green) to one of the water molecules
while R47 forms a hydrogen bond with D2. Thus, while there is
some re-arrangement of interactions, the nature of environment
remains similar as a result of the exchange. The conservative
nature of the substitution and its distance from the active site
suggest H47R would have no effect on enzyme activity or
substrate binding. These data concur with the findings of
Takahashi et al.[4] who showed no significant difference in
either Vmax or Km for the H47R variant (Table 1).
S87C variant. The SND rs13933 corresponds to the S87C
variant. This variant involves a conservative exchange of one small
polar residue (serine) for another (cysteine). The environment
around residue 87 is shown in Figure S8. Interestingly, S (serine,
shown in orange) and C (cysteine, shown in magenta), adopt
different rotamers. S87C exists in a heterogeneous environment
surrounded by a mixture of the hydrophobic residues W86, F118,
V120, V122, and F311, along with the positively charged H90
(shown in cyan) and two water molecules (shown in blue). The
position of residue 87 is also close to the active site, with W86 also
in close proximity to the substrate. Upon exchange, the pattern of
hydrogen bonding (shown in green) with the adjacent water
molecules changes. Nonetheless, the conservative nature of the
change does not strongly alter the local environment, suggesting
S87C would have no effect on enzyme activity or substrate
binding. These data concur with the findings of Takahashi et al.[4]
who showed no significant difference in either Vmax or Km for the
S87C variant (Table 1).
H170R variant. The H170R variant corresponds to the
rs10618 SND. It involves a conservative exchange of one large,
positively charged residue (histidine) for another (arginine). Figure
S9 shows the environment around residue 170. Both H (histidine,
shown in orange) and R (arginine, shown in magenta) adopt the
same rotamer. H47R exists in a heterogeneous environment, on
the surface of the molecule and distant from the active site. While
close to the hydrophobic F205 and the polar Y323, it is also near
the negatively charged E174 (shown in cyan) and a number of
water molecules (shown in blue). Both H and R form hydrogen
bonds (shown in green) with the water molecules, although the
arrangement is different. The conservative nature of the
substitution, its location on the surface of the molecule, and its
distance from the active site suggest H170R would have no effect
on enzyme activity or substrate binding. These data concur with
the findings of Takahashi et al.[4] who showed no significant
difference in either Vmax or Km for the H47R variant (Table 1).
L172Q variant. The SND rs11474 corresponds to the
L172Q variant. This variant involves exchanging a small
hydrophobic residue (leucine) for a relatively small hydrophilic
residue, glutamine.
Functional Analyses of AKR1C1/2 SNPs
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Figure 4 shows the environment of residue 172. Again, both L
(leucine) and Q (glutamine) adopt the same rotamer. The normal
(WT) L172 (shown in orange) is surrounded by two groups of
residues (shown in cyan; Figure 4). Those closer to the surface are
charged (R171) or polar (N169 and N316), with N316 and R171
sharing a hydrogen bond. In contrast, those in the interior of the
molecule are non-polar (P119, L144, F168, and P318).
N167 (shown in red; Figure 4) is also located on the very edge
of the local environment of residue 172 and closer still to the non-
polar environment created by P119, F168, and P318. N167 forms
a hydrogen bond (shown in green) with carboxy-amide group of
the nicotinamide ring of the NADP cofactor[14] (shown in purple).
The introduction of the polar L172Q variant (shown in
magenta; Figure 4) into the non-polar environment at the core
of the protein is likely to disrupt this environment as it seeks to
accommodate the new polar residue. The proximity of this non-
polar environment to N167 leads to the hypothesis that it too will
be affected by this adjustment, disrupting the hydrogen bond with
the cofactor and hence contributing to instability in the binding of
the cofactor. This disruption would be predicted to result in a drop
in enzyme activity (Vmax) and this is confirmed by the original
experimental findings of Takahashi et al.[4].
However, in contrast, Takahashi et al.[4] also show a statistically
significant decrease in the Km of binding of the DHT substrate.
This implies the DHT substrate is more strongly bound as a result of
the L172Q substitution. The site of the L172Q substitution is at a
distance from the binding site of the testosterone molecule in our
model and thus does not provide any strong rationale for the
improved binding of DHT (Table 1).
The R258C AKR1C1 variant
Most of the reported SNPs in AKR1C1 are actually SNDs[8],
leaving only one non-synonymous substitution, rs28943580 which
results in the R258C variant which substitutes the normal arginine
with cysteine, analogous to the R258C variant in AKR1C2.
Figure 5 displays the local environment of residue 258. Both the
R and C residues adopt the same rotamer. While there are some
slight differences in the environment of R258C in AKR1C1 and
AKR1C2, the major features are similar. R258 residue exists in a
heterogeneous environment comprising polar Q262 and Q287
residues and non-polar L261 and F284 residues (shown in cyan).
The interaction between the R258 and the polar residues,
particularly Q262, along with the water molecule (shown in blue)
around the surface of the protein stabilizes this environment. The
R258C substitution (shown in magenta) breaks these stabilizing
interactions and draws the residue deeper into more hydrophobic
core of the protein in proximity to V283, F286, and L288 (shown
in cyan), although presumably the polar Q262 residue, also being
present in the local environment, maintains some stability.
As for the AKR1C2 R358C substitution, in AKR1C1 the
substitution results in a slight worsening in ProSA-web z-score,
from 211.49 to 211.42 and also in the Verify3D score: up to 0.62
from 0.60. The MolProbity clash score rises from 7.31 to 13.55 but
no new clash arises due to the substitution. The accessible surface
area drops from 11.24 to 3.60, in line with the observation above
that the substitution results in the sidechain being drawn further
into the core of the protein.
Once again, this amino acid substitution is located at some
distance from the active site and on the surface of the molecule.
Thus, despite the changes noted above, the substitution does not
suggest any effect on the enzyme activity of AKR1C1 or the
binding of the substrate or cofactor (Table 1).
Discussion
The gene products of the AKR1C1 and AKR1C2 genes
catalyze important reactions in the formation and inactivation of
male and female sex hormones (Figure 1). In their study of the
enzyme kinetics of AKR1C2, Takahashi et al.[4] showed two non-
synonymous single nucleotide changes, corresponding to the F46Y
and L172Q variants, resulted in reduced enzyme activity. In this
study, our modeling confirms this result, showing F46Y (the result
of a SNP) and L172Q (the result of a SND) both potentially
disrupt hydrogen bonding between the enzyme and the NADP
cofactor (Figure 3 and Figure 4). Thus, we hypothesize that the
reduced enzyme activity reported by Takahashi et al.[4] resulting
from either of these two substitutions results from a more weakly
bound cofactor. This could be confirmed by measuring the Km of
the cofactor in an experiment analogous to those already
undertaken by Takahashi et al.[4] in measuring the Km of the
DHT substrate. Furthermore, this hypothesis is also supported by
the reduced Km of the DHT substrate in L172Q, indicating the
Figure 4. The L172Q substitution in the AKR1C2 predicted
protein disrupts the non-polar environment near N167. The
environment of residue 172 shows both the L and Q variants adopt the
same rotamer. The variant introduces a polar residue into a largely non-
polar environment close by N167, which forms a hydrogen bond with
the nicotinamide ring of the cofactor.
doi:10.1371/journal.pone.0015604.g004
Figure 5. The R258C moves a polar residue into the non-polar
core. The environment of residue 258 in AKR1C1 shows both the R
(orange) and C (magenta) variants adopt the same rotamer. Residue 258
is located on the surface of the protein and distant from the active site.
The introduction of the C residues brings the polar residue further into
the non-polar core of the protein including V283, F286, and L288 (cyan).
doi:10.1371/journal.pone.0015604.g005
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DHT is more strongly bound, and thus not likely to be the source
of the reduced enzyme activity.
The other four SNPs (V111A, K179E, K185E, and R258C) and
other five SNDs (V38I, V38A, H47R, S87C, H170R) did not show
reduced enzyme activity in the experimental analysis of Takahashi
et al.[4]. Our modeling supports this finding. We have shown these
substitutions to be either conservative (V111A, V38I, V38A,
H47R, S87C, H170R), or to exist on the surface of the molecule
and distant from the active site (K179E, K185E, and R258C), and
thus they are unlikely to directly effect enzyme activity, substrate
binding, or cofactor binding. We hypothesize that measurement of
the Km of cofactor binding in these variants would should no
significant difference to the normal (WT) enzyme.
Similarly, in modeling the R258C amino acid substitution in the
predicted AKR1C1 gene product, we find the substitution occurs
on the surface of the molecule, distant from the active site. We thus
hypothesize that similar enzyme kinetic experiments on AKR1C1
would show that R258C does not reduce enzyme activity or
significantly change either progesterone or NADP binding
compared to the wild type.
One finding by Takahashi et al.[4] not explained by our
modeling is the increased DHT binding (measured as reduced Km
by Takahashi et al.[4]) in the V38A, L172Q, K185E, and R258C
variants. It is possible that the general disruptiveness of these
substitutions, in terms of broken salt bridges and hydrogen bonds,
along with the drawing of polar or charged residues into the more
non-polar core of the molecule (in the case of the latter three) or
the removal of proximal hydrophobic interactions (in the case of
V38A), may result in a general ‘‘opening up’’ of the core of the
molecule making it easier for the DHT molecule to enter and bind
in the active site. However, this is highly speculative and would
need to be confirmed by further experiments. In this regard, we
note that numerous crystal structures of AKR1C2 already exist
(including PDB accession numbers: 2HDJ[25], 1IHI[24],
1J96[14], 1XJB[26], 2IPJ[27]). This suggests the crystallization
conditions of AKR1C2 are well known, making it feasible that
crystal structures of the variant proteins could be determined,
potentially helping to explain any more substantial re-arrange-
ments of structure that may occur as a result of these variants.
It is also worth considering the possibility that AKR1C2 may
act as a homodimer. In this case, residues on the surface of the
protein may be distant from the active site, but involved in the
stabilization of the homodimer. Thus, changes to these residues
may affect the function of the enzyme through destablization of
the biological unit. The PDB records of the five crystal structures
for AKR1C2 give mixed information regarding the nature of the
biological unit, with some indicating a dimer and some a
monomer. Furthermore, there is no mention of the biological
unit in the research papers associated with these database entries.
Nor could we find reference to the nature of the biological unit in a
literature search. Using ProtCID[28], we identified that the
interface in the asymmetric unit of 1J96 is shared by a 40%
homologue: 2,5-diketo-D-gluconic acids reductase A from Coryne-
bacterium sp. This provides some evidence to support the existence
of a homodimer. Cross-referencing the list of SNP and SND
variants against the residues near the interface, as provided by
ProtCID, showed that only the R258C SNP and the H47R SND
were near the interface, although still not making contact with
residues in the other domain. Thus, even if the homodimer were
confirmed, none of the variant residues considered would appear
to mediate their effect on the biochemistry of the enzyme through
destabilization of the dimer.
Finally, we also note the complexity of the various kinetic
parameters in an ordered bi-bi reaction, such as the one catalyzed
by AKR1C2. Jin and Penning[29] showed the rate determining
step of the reaction catalyzed by AKR1C2 depends on both the
enzyme and the substrate, with several steps, including cofactor
release and steroid release contributing to the rate of reaction. Our
results are compatible with this finding. In particular, we suggest
the reduced enzyme activity of the F46Y and L172Q variants may
be mediated through destabilization of the cofactor. Thus, the
cofactor position may be altered from the ideal found in the wild
type, slowing the rate of reaction. However, the complexity of the
reaction dynamics also raises alternative possibilities, such as the
potential for a destabilized cofactor to be released faster and thus
increase the reaction rate. Our results suggest one possible
mechanism and thus provide a basis for the development of
further experiments to determine the contribution of these
structural changes to the biochemistry of AKR1C2.
The careful and thorough experiments of Takahashi et al.[4]
help to further highlight the potential issues that may arise from
the contamination of SNP databases with single nucleotide
differences (SNDs)[8]. Some implications of SNDs and other
database errors have been discussed by Day[9]. In this case, eleven
variants of AKR1C2 were chosen for experimental analysis on the
basis of their listing in the widely used dbSNP database[7].
Expression constructs were created and rigorous kinetic experi-
ments conducted for each variant: presumably at a considerable
cost in terms of research time and consumables. Yet, reference to
our SND data shows six of these variants (rs3207901, rs3207898,
rs3207905, rs13933, rs10618, rs11474) to be SNDs rather than
SNPs.
This in no way diminishes the work of Takahashi et al.[4]
completed prior to the publication of our SND analysis[8]. The
biochemical analysis of all the variants tested still stands and these
effects can be further explored with homology modeling as we
have shown. However, the significance of the findings in relation
to the SND variants is reduced since these particular variants have
not yet been established as natural genetic variants. For example,
V38A and L172Q were shown to have a significant effect on DHT
binding, but this is not as significant as the findings in relation to
F46Y and the other four variants derived from SNPs, as V38A and
L172Q have not yet been established to occur naturally.
The AKRIC1 and AKR1C2 genes are involved in sex steroid
metabolism, metabolizing progesterone and 5a-dihydrotestoster-
one respectively (Figure 1). As mentioned previously, AKR1C1
has a role in controlling plasma progesterone levels in pregnancy
[3] while AKR1C2 has been linked to prostate cancer [5,6]. Thus,
our comparative modeling and analysis of the effect of SNPs may
provide useful functional insights into the role of sex steroid
metabolism in pregnancy, prostate cancer, and other disorders,
particularly where SNP and haplotype analysis is used.
Due to the potential for considerable time and money to be
invested in studies of supposed SNPs that are actually SNDs, it
important that further efforts are made to clean and curate our
online SNP repositories to remove, or at least flag as ‘‘suspect’’,
these SNDs. Pending these changes, researchers should carefully
and thoroughly explore the SNPs they choose for use in their
analysis [8,9].
Supporting Information
Figure S1 V111A is a conservative mutation. The
environment of residue 111 shows both the V (orange) and A
(magenta) variants. The introduction of the A residue is a
conservative mutation, distant from the active site, and located
on the periphery of the protein.
(TIF)
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Figure S2 K179E breaks a surface salt-bridge. The
environment of residue 179 shows both the K (orange) and E
(magenta) variants adopt the same rotamer. Residue 179 is located
on the surface of the protein and distant from the active site. The
introduction of the E residue breaks a salt bridge with nearby E149
and E152 (cyan) and brings the charge further into the non-polar
core of the protein including W148, I176, and L182 (cyan).
(TIF)
Figure S3 K185E moves a charged residue into the non-
polar core. The environment of residue 185 shows both the K
(orange) and E (magenta) variants adopt the same rotamer.
Residue 185 is located on the surface of the protein and distant
from the active site. The introduction of the E residue brings the
charge further into the non-polar core of the protein including
L177 and L182 (cyan).
(TIF)
Figure S4 R258C moves a polar residue into the non-
polar core. The environment of residue 258 shows both the R
(orange) and C (magenta) variants adopt the same rotamer.
Residue 258 is located on the surface of the protein and distant
from the active site. The introduction of the C residue brings the
polar residue further into the non-polar core of the protein
including V283, F286, and L288 (cyan).
(TIF)
Figure S5 V38I is a conservative mutation. The environ-
ment of residue 38 shows both the V (orange) and I (magenta)
variants adopt the same rotamer. The introduction of the I residue
is a conservative mutation distant from the active site.
(TIF)
Figure S6 V38A disrupts the local hydrophobic environ-
ment. The environment of residue 38 shows both the V (orange)
and A (magenta) residues. The introduction of the A residue, while
conservative, does remove many proximal interactions with other
hydrophobic residues.
(TIF)
Figure S7 H47R is a conservative mutation. The environ-
ment of residue 47 shows both the H (orange) and R (magenta)
variants adopt the same rotamer. The introduction of the R
residue is a conservative mutation distant from the active site.
(TIF)
Figure S8 S87C is a conservative mutation. The environ-
ment of residue 87 shows S (orange) and C (magenta) adopt a
different rotamer. Despite this change, and close proximity to the
active site, the introduction of the C residue is a conservative
mutation with little effect on the local environment.
(TIF)
Figure S9 H170R is a conservative mutation. The
environment of residue 170 shows both the H (orange) and R
(magenta) variants adopt the same rotamer. The introduction of
the R residue is a conservative mutation distant from the active site
and located on the surface of the protein.
(TIF)
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